UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Antiviral research, 2021-11, Vol.195, p.105180-105180, Article 105180

2021

Volltextzugriff (PDF)

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

Antiviral research, 2017-01, Vol.137, p.14-22

2017

Volltextzugriff (PDF)

Preclinical Characterization of BCX7353, an Oral Plasma Kallikrein Inhibitor, for the Treatment of Hereditary Angioedema (HAE)

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB230-AB230

2017

Volltextzugriff (PDF)

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

Antiviral research, 2012-04, Vol.94 (1), p.103-110

2012

Volltextzugriff (PDF)

A Simple, Sensitive and Selective Fluorogenic Assay to Monitor Kallikrein Activity in Activated Plasma

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB210-AB210

2013

Volltextzugriff (PDF)

BCX7353, a Potent Inhibitor of Plasma Kallikrein, Shows Sustained Maximal Enzyme Inhibition When Dosed Orally Once Daily: Results from a Phase I Trial in Healthy Subjects

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB401-AB401

2016

Volltextzugriff (PDF)

BCX-4161, a Small Molecule and Orally Bioavailable Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB211-AB211

2013

Volltextzugriff (PDF)

A Simple, Sensitive and Selective Fluorogenic Assay To Monitor Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Plasma

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB40-AB40

2014

Volltextzugriff (PDF)

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice

Antiviral research, 2011-04, Vol.90 (1), p.17-21

2011

Volltextzugriff (PDF)

An efficient triphosphate synthesis of a novel broad-spectrum antiviral nucleoside BCX4430

Tetrahedron letters, 2023-01, Vol.114, p.154219, Article 154219

2023

Volltextzugriff (PDF)

Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases

European journal of medicinal chemistry, 2024-01, Vol.264, p.115991-115991, Article 115991

2024

Volltextzugriff (PDF)

Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors

Bioorganic & medicinal chemistry, 2022-11, Vol.74, p.117034-117034, Article 117034

2022

Volltextzugriff (PDF)

Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase

The Journal of biological chemistry, 2017-09, Vol.292 (38), p.15907-15915

2017

Volltextzugriff (PDF)

Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon

Bioorganic & medicinal chemistry, 2022-11, Vol.73, p.117035-117035, Article 117035

2022

Volltextzugriff (PDF)

Effectiveness of the Guidelines for the Non-Operative Management of Knee Osteoarthritis

Archives of bone and joint surgery, 2021-07, Vol.9 (4), p.472-474

2021

Volltextzugriff (PDF)

Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme

Antiviral research, 2011-09, Vol.91 (3), p.288-291

2011

Volltextzugriff (PDF)

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice

Antiviral research, 2010-10, Vol.88 (1), p.38-44

2010

Volltextzugriff (PDF)

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

Antiviral research, 2010-12, Vol.88 (3), p.276-280

2010

Volltextzugriff (PDF)

Discovery of highly potent small molecule kallikrein inhibitors

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2006-11, Vol.2 (6), p.545-553

2006

Volltextzugriff (PDF)

IoT based Water Quality Monitoring System Using WSN

Indian journal of public health research and development., 2018-12, Vol.9 (12), p.1575

2018

Volltextzugriff (PDF)

Combination of Peramivir and Rimantadine Demonstrate Synergistic Interaction in Influenza a Mouse Model

Antiviral research, 2010-04, Vol.86 (1), p.A29-A29

2010

Volltextzugriff (PDF)

BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged With Zika Virus

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Antiviral Drug Efficacy Evaluation Against Pandemic Influenza a (H1N1) Viruses in MDCK Cells

Antiviral research, 2010-04, Vol.86 (1), p.A48-A48

2010

Volltextzugriff (PDF)

A Single Intramuscular Injection of Peramivir Demonstrates Anti-influenza Activity Against Recently Isolated Pandemic Flu Virus H1N1 (A/CA/04/2009)

Antiviral research, 2010-04, Vol.86 (1), p.A29-A30

2010

Volltextzugriff (PDF)

Efficacy of Combinations of Oseltamivir and Peramivir in Treating Influenza a (H1N1) Virus Infections in Cell Culture and in Mice

Antiviral research, 2010-04, Vol.86 (1), p.A47-A47

2010

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(66)
Tagungsberichte
(1)

Sprache

Englisch
(67)
Japanisch
(7)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

Preclinical Characterization of BCX7353, an Oral Plasma Kallikrein Inhibitor, for the Treatment of Hereditary Angioedema (HAE)

Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice

A Simple, Sensitive and Selective Fluorogenic Assay to Monitor Kallikrein Activity in Activated Plasma

BCX7353, a Potent Inhibitor of Plasma Kallikrein, Shows Sustained Maximal Enzyme Inhibition When Dosed Orally Once Daily: Results from a Phase I Trial in Healthy Subjects

BCX-4161, a Small Molecule and Orally Bioavailable Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema

A Simple, Sensitive and Selective Fluorogenic Assay To Monitor Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Plasma

A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice

An efficient triphosphate synthesis of a novel broad-spectrum antiviral nucleoside BCX4430

Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases

Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors

Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase

Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon

Effectiveness of the Guidelines for the Non-Operative Management of Knee Osteoarthritis

Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice

Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model

Discovery of highly potent small molecule kallikrein inhibitors

IoT based Water Quality Monitoring System Using WSN

Combination of Peramivir and Rimantadine Demonstrate Synergistic Interaction in Influenza a Mouse Model

BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged With Zika Virus

Antiviral Drug Efficacy Evaluation Against Pandemic Influenza a (H1N1) Viruses in MDCK Cells

A Single Intramuscular Injection of Peramivir Demonstrates Anti-influenza Activity Against Recently Isolated Pandemic Flu Virus H1N1 (A/CA/04/2009)

Efficacy of Combinations of Oseltamivir and Peramivir in Treating Influenza a (H1N1) Virus Infections in Cell Culture and in Mice

Suchergebnisse filtern